Medical Research
-
Sea Squirt from Antarctic Depths Holds Promise for Melanoma Treatment
ANTARCTICA, July 8 — A marine organism discovered during a scientific expedition to Antarctica is now being studied as a potential new…
-
Two Antibody Drugs Now Slow Early Alzheimer’s Decline, With Brain-Swelling Risks
WASHINGTON — For the millions of American families touched by Alzheimer’s disease, the past few years have brought something that once felt…
-
Northwestern Chemists Confirm Structures of Two Rye Pollen Molecules Tied to Tumor Clearance in Animals
MANILA, July 7 — A team of scientists has identified two new molecules from rye pollen that could one day change how…
-
Strengthening Alberta’s Clinical Trial Infrastructure with New Funding
EDMONTON, July 7 — A significant investment in clinical trials is set to transform cancer care in Alberta, with the Alberta Cancer…
-
BEYOND-PSA Study Invites 10,000 London Men to Test New Prostate Blood Test
LONDON, July 7 — A charity dedicated to tackling the most common cancer in men is hoping a new fundraising drive will…
-
Owerko Centre Among Sites Sharing Alberta Cancer Foundation’s $35M Trials Fund
CALGARY, July 7 — A major investment announced yesterday is set to transform how quickly families across Alberta, and potentially beyond, can…
-
Tel Aviv researchers uncover cancer growth mechanism
TEL AVIV, July 4 — Researchers at Tel Aviv University have documented a mechanism by which cancerous tumors hijack a routine immune-system…
-
Modified Vitamin B12 Crosses Blood-Brain Barrier and Targets Glioblastoma in Animal Study
Glioblastoma kills. It kills fast. Most patients get fifteen months, if they’re lucky. Surgery, radiation, chemotherapy — the standard toolkit — rarely…
-
Researchers Use Vitamin B12 to Deliver Glioblastoma Drug Past Blood-Brain Barrier
History is littered with promising cancer treatments that worked beautifully in mice and then fell apart in people. That sobering fact hangs…
-
Fatty Liver Linked to More Aggressive Spread of Bowel Cancer to the Liver, Study Finds
LONDON, July 3 — A fatty liver may be more than a metabolic warning sign. New research published in the journal Nature…
-
Modified vitamin B12 compound reaches brain tumors in animal study and stays active
A modified vitamin B12 compound that sneaks past the brain’s defenses has cleared animal testing for glioblastoma. The next steps are concrete,…
-
Modified B12 compound with nitric oxide targets glioblastoma in animal tests
Glioblastoma patients have a grim clock. Median survival: under 15 months. Even with surgery, radiation, and chemotherapy, the tumor almost always returns.…
-
Mouse Study Links Alcohol Flush Gene to Alzheimer’s-Related Brain Changes
For millions of people, a glass of wine brings an immediate, unmistakable flush. That red face has long been dismissed as a…
-
Nebraska Professor Turns Parents’ Cancer Deaths in Kenya Into Classroom Campaigns
LAGOS, July 1 — For years, I taught my students about the mechanics of writing, about narrative structure and clarity. But the…
-
Phage Display, the Virus-Based Method Behind Humira, Earned a 2018 Chemistry Nobel
NEW YORK, July 1 — There is a quiet revolution happening in a corner of biotechnology that most people have never heard…
-
Spanish Researcher Builds CAR-T Cells Against Rare Childhood Rhabdoid Tumours
A single gene gone wrong. That is the core problem with rhabdoid tumours. And it is the core clue that a Spanish…
-
Omega-3 health update after major new study into claims
LOS ANGELES, June 30 — 365 older adults. Two years. Zero measurable brain benefit from fish oil supplements. That is the bottom…
-
High-Dose Fish Oil Shows No Cognitive Benefit in Older Adults at Alzheimer’s Risk
LOS ANGELES — For two years, researchers tracked 365 older adults who took high doses of fish oil. The result, published by…
-
Buckie trainee ambulance technician, in remission from rare lymphoma, launches Aberdeen Race for Life
ABERDEEN — Dr. Gavin Preston delivered the news on June 22 last year. He told Kayla Esson the cancer was gone. For…
-
A third of people with cancer red-flag symptoms did not see a GP for six months
LONDON — A troubling new picture of how Brits respond to possible cancer symptoms has emerged, with research showing that a third…
-
Antarctic sea creature toxin shows melanoma-killing potential in mouse study
A toxin harvested from a tiny sea creature collected off Antarctica has killed melanoma in mice without harming the mice. That fact…
-
Stomach Cancer Surge in Under-50s: Experts Reveal Key Risk Factors
GREENVILLE, S.C., June 28 — Carly Douglas was 34 years old, a mother of three, and an influencer with 140,000 Instagram followers.…
-
Menopause Hormone Therapy Linked to 69% Lower Risk of Low Bone Density
CHICAGO — New research presented Sunday at the Endocrine Society’s annual meeting is forcing a strategic recalculation of how doctors and patients…
-
Cleveland study finds vitamin B12 compound may cross blood-brain barrier to treat glioblastoma
CLEVELAND — Fifteen months. That is the average survival time for a patient diagnosed with glioblastoma. Surgery, radiation, chemotherapy — standard care…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992